Skip to content
Open access · CC-BY via OpenAlex

Metabolic reprogramming of pulmonary fibrosis

Jiaxin Li, Xiaoxuan Zhai, Xiao Sun, Shengchuan Cao, Qiuhuan Yuan, Jiali Wang

Frontiers in Pharmacology · 2022 · ▲ 55 citations

Abstract

Pulmonary fibrosis is a progressive and intractable lung disease with fibrotic features that affects alveoli elasticity, which leading to higher rates of hospitalization and mortality worldwide. Pulmonary fibrosis is initiated by repetitive localized micro-damages of the alveolar epithelium, which subsequently triggers aberrant epithelial-fibroblast communication and myofibroblasts production in the extracellular matrix, resulting in massive extracellular matrix accumulation and interstitial remodeling. The major cell types responsible for pulmonary fibrosis are myofibroblasts, alveolar epithelial cells, macrophages, and endothelial cells. Recent studies have demonstrated that metabolic reprogramming or dysregulation of these cells exerts their profibrotic role via affecting pathological mechanisms such as autophagy(definition), apoptosis, aging, and inflammatory responses, which ultimately contributes to the development of pulmonary fibrosis. This review summarizes recent findings on metabolic reprogramming that occur in the aforementioned cells during pulmonary fibrosis, especially those associated with glucose, lipid, and amino acid metabolism, with the aim of identifying novel treatment targets for pulmonary fibrosis.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3389/fphar.2022.1031890
Canonical
link ↗
Fetched
2026-10-24 MST

Cite this

APA
Li, J., Zhai, X., Sun, X., Cao, S., Yuan, Q., &amp; Wang, J. (2022). Metabolic reprogramming of pulmonary fibrosis. <em>Frontiers in Pharmacology</em>. https://doi.org/10.3389/fphar.2022.1031890
Vancouver
Li J, Zhai X, Sun X, Cao S, Yuan Q, Wang J. Metabolic reprogramming of pulmonary fibrosis. Frontiers in Pharmacology. 2022. doi:10.3389/fphar.2022.1031890.
BibTeX
@article{jiaxin2022Metabo, title = {Metabolic reprogramming of pulmonary fibrosis}, author = {Jiaxin Li and Xiaoxuan Zhai and Xiao Sun and Shengchuan Cao and Qiuhuan Yuan and Jiali Wang}, journal = {Frontiers in Pharmacology}, year = {2022}, doi = {10.3389/fphar.2022.1031890}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings